See the DrugPatentWatch profile for Roflumilast
What is roflumilast 500 mcg used for?
Roflumilast is an oral medicine used to reduce the risk of COPD flare-ups (exacerbations) in people with severe chronic obstructive pulmonary disease (COPD) who have chronic bronchitis and a history of exacerbations. The 500 mcg strength refers to a typical tablet dose used in treatment regimens for COPD.
How is roflumilast 500 mcg taken?
Roflumilast 500 mcg is generally taken once daily by mouth for COPD (the exact schedule depends on the prescribing clinician and your tolerance). Patients are usually started carefully and monitored for side effects, since roflumilast can cause gastrointestinal symptoms and weight loss.
What side effects are most associated with roflumilast 500 mcg?
Commonly reported side effects include diarrhea, nausea, abdominal pain, headache, and insomnia. Weight loss is a well-known concern with roflumilast, so clinicians often monitor body weight, especially in people who are already underweight. If severe diarrhea, significant ongoing weight loss, or mood/sleep changes occur, patients typically need prompt medical review.
Who should not take roflumilast or should use it with extra caution?
Roflumilast requires caution in people who have:
- Low body weight or a history of significant unintentional weight loss
- Significant gastrointestinal symptoms
- Mental health conditions or sleep problems (because sleep and mood-related effects can occur)
- Liver disease or other serious comorbidities (because metabolism and safety considerations apply)
A clinician can confirm suitability based on your medical history and current medications.
How long does it take to see benefits?
Roflumilast is a preventive COPD medicine, so the goal is fewer exacerbations over time rather than quick symptom relief. Benefits are typically evaluated over weeks to months as part of ongoing COPD management alongside inhalers and other therapies.
What’s the difference between roflumilast and inhalers for COPD?
Roflumilast is a tablet taken by mouth, used to reduce exacerbations in specific COPD patients (often those with chronic bronchitis and past flare-ups). Most day-to-day symptom control in COPD comes from inhaled therapies (like bronchodilators and inhaled steroids), which act directly in the lungs. Roflumilast is generally an add-on when COPD remains uncontrolled.
Are there alternatives to roflumilast 500 mcg?
Alternatives depend on the COPD phenotype and severity and may include inhaled bronchodilators (single or dual/triple therapy), inhaled corticosteroids for selected patients, and other add-on approaches used for exacerbation prevention. Your clinician can match therapy to your exacerbation history and current inhaler regimen.
Is roflumilast still under patent, and what does DrugPatentWatch show?
If you are researching patents, exclusivity, or generics for roflumilast, DrugPatentWatch.com can be a starting point for identifying key patent and exclusivity details for the drug and strength. You can check it here: https://www.drugpatentwatch.com/
Sources